Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38935923

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2024 Nov
First author
Tarantino P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Gland Surg. 2025 Apr 30;14(4):785-790. doi: 10.21037/gs-2025-23.
    note
    Source null
    related pmid
    40405946
    relationship
    Comment in
  2. citation
    Gland Surg. 2025 May 30;14(5):803-806. doi: 10.21037/gs-2025-41.
    note
    Source null
    related pmid
    40546847
    relationship
    Comment in

Authors and identifiers

  1. name
    Tarantino P
    type
    Author
  2. name
    Tayob N
    type
    Author
  3. name
    Villacampa G
    type
    Author
  4. name
    Dang C
    type
    Author
  5. name
    Yardley DA
    type
    Author
  6. name
    Isakoff SJ
    type
    Author
  7. name
    Valero V
    type
    Author
  8. name
    Faggen M
    type
    Author
  9. name
    Mulvey T
    type
    Author
  10. name
    Bose R
    type
    Author
  11. name
    Weckstein D
    type
    Author
  12. name
    Wolff AC
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Tarantino P
    type
    Author
  2. name
    Tayob N
    type
    Author
  3. name
    Villacampa G
    type
    Author
  4. name
    Dang C
    type
    Author
  5. name
    Yardley DA
    type
    Author
  6. name
    Isakoff SJ
    type
    Author
  7. name
    Valero V
    type
    Author
  8. name
    Faggen M
    type
    Author
  9. name
    Mulvey T
    type
    Author
  10. name
    Bose R
    type
    Author
  11. name
    Weckstein D
    type
    Author
  12. name
    Wolff AC
    type
    Author
bibliography ids
  1. nci-bib-fe2ced7f4d49c0fc4d080f00
book metadata
content sha256
6b7b43a872c36f27f12d1895e4576baf26b17e889960c268c692b59d73d278b5
document type
citation
dois
  1. 10.1200/JCO.23.02170
electronic publication date
display
2024 Jun 27
precision
day
year
2024
evidence scope
bibliographic_metadata_only
id
pubmed:38935923
immutable id
pubmed:38935923@6b7b43a872c36f27f12d1895e4576baf26b17e889960c268c692b59d73d278b5
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
31
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3652-3665
volume
42
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Gland Surg. 2025 Apr 30;14(4):785-790. doi: 10.21037/gs-2025-23.
    note
    Source null
    related pmid
    40405946
    relationship
    Comment in
  2. citation
    Gland Surg. 2025 May 30;14(5):803-806. doi: 10.21037/gs-2025-41.
    note
    Source null
    related pmid
    40546847
    relationship
    Comment in
outcomes validated
false
pmid
38935923
provenance
batch id
3e43afde6f26fc8df6da
provider
NCBI PubMed ESummary
record sha256
75a0df631d7ec621843b601e402970938cc6d45be91c32481790719306f40cdd
response sha256
fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
retrieved at
2026-09-09T23:48:21.145285+00:00
publication date
display
2024 Nov
precision
month
year
2024
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Clinical Trial, Phase II
  4. Multicenter Study
  5. Comparative Study
  6. Research Support, Non-U.S. Gov't
  7. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38935923/
title
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.

Preserved source evidence · Not medical advice